Inhibition of IRE1 endonuclease activity attenuates the secretion of pro-inflammatory cytokines and enhances chemotherapeutic drug-mediated tumor suppression, suggesting that inhibition of IRE1 can potentiate the efficacy of chemotherapeutics for TNBC treatment [133]. Here, ERN1 is linked to neoplasm.